CAS: 848133-17-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | HKI 357 REF: IN-DA00GAICCAS: 848133-17-5 | 98% | To inquire | Tue 04 Mar 25 |
 | HKI 357 REF: 3D-YIB13317CAS: 848133-17-5 | Min. 95% | To inquire | Tue 15 Apr 25 |
 | HKI-357 REF: TM-T11569CAS: 848133-17-5 | 95.11% | 79.00 €~938.00 € | Tue 06 May 25 |
Ref: IN-DA00GAIC
| 10mg | 161.00 € | ||
| 25mg | 229.00 € | ||
| 50mg | 481.00 € | ||
| 100mg | 620.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
HKI 357
CAS:848133-17-5
HKI 357 is a small molecule that binds to the voltage-gated potassium channel, inhibiting it. …
Formula:
C31H29ClFN5O3
Purity:
Min. 95%
Molecular weight:
574.05 g/mol
Ref: 3D-YIB13317
| 25mg | 1,216.00 € | ||
| 50mg | 1,692.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
HKI-357
CAS:848133-17-5
HKI-357 irreversibly inhibits EGFR/ERBB2 (IC50: 34/33 nM), blocks EGFR Y1068 autophosphorylation, and AKT/MAPK phosphorylation.
Formula:
C31H29ClFN5O3
Purity:
95.11%
Color and Shape:
Solid
Molecular weight:
574.05
Ref: TM-T11569
| 1mg | 79.00 € | ||
| 5mg | 153.00 € | ||
| 10mg | 227.00 € | ||
| 25mg | 462.00 € | ||
| 50mg | 662.00 € | ||
| 100mg | 938.00 € | ||
| 1mL*10mM (DMSO) | 187.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
